Hanall Biopharma Co., Ltd. (KRX:009420)
South Korea · Delayed Price · Currency is KRW 51,500
-2,200 (-4.10%)
Jan 30, 2026, 3:30 PM KST
25.15% (1Y)
| Market Cap | 2.62T +28.6% |
| Revenue (ttm) | 154.05B +14.8% |
| Net Income | 2.31B |
| EPS | 45.51 |
| Shares Out | 50.78M |
| PE Ratio | 1,131.95 |
| Forward PE | 297.55 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 489,561 |
| Average Volume | 709,826 |
| Open | 52,300 |
| Previous Close | 53,700 |
| Day's Range | 50,800 - 52,700 |
| 52-Week Range | 24,000 - 57,100 |
| Beta | 0.72 |
| RSI | 55.54 |
| Earnings Date | Mar 6, 2026 |